X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.500
+0.170 (5.11%)
At close: Mar 4, 2026, 4:00 PM EST
3.450
-0.050 (-1.43%)
After-hours: Mar 4, 2026, 4:38 PM EST
X4 Pharmaceuticals Stock Forecast
XFOR's stock price has decreased by -67.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for X4 Pharmaceuticals stock have an average target of 28.5, with a low estimate of 5.00 and a high estimate of 90. The average target predicts an increase of 714.29% from the current stock price of 3.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 5, 2025.
Analyst Ratings
The average analyst rating for X4 Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $7.5 → $10 | Strong Buy | Maintains | $7.5 → $10 | +185.71% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.5 → $5 | Strong Buy | Maintains | $3.5 → $5 | +42.86% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $30 → $9 | Strong Buy | Maintains | $30 → $9 | +157.14% | Aug 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3.5 | Strong Buy | Maintains | $7 → $3.5 | n/a | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $7 | Strong Buy | Maintains | $1.5 → $7 | +100.00% | May 2, 2025 |
Financial Forecast
Revenue This Year
34.88M
from 2.56M
Increased by 1,263.94%
Revenue Next Year
11.47M
from 34.88M
Decreased by -67.11%
EPS This Year
-2.73
from -5.59
EPS Next Year
-1.11
from -2.73
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 36.2M | 17.3M | ||||
| Avg | 34.9M | 11.5M | ||||
| Low | 33.3M | 6.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1,315.8% | -50.5% | ||||
| Avg | 1,263.9% | -67.1% | ||||
| Low | 1,203.1% | -82.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.37 | -0.75 | ||||
| Avg | -2.73 | -1.11 | ||||
| Low | -3.04 | -1.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.